UnitedHealth, Cigna shares fall after Raymond James downgrades, citing tripledemic and coverage issues
Shares of UnitedHealth Group Inc.
UNH,
fell 0.5% and Cigna Corp.
CI,
slumped 2.3% in premarket buying and selling Monday, after Raymond James analyst John Ransom downgraded the well being insurers, citing issues that the “tripledemic” of the flu, RSV (respiratory syncytial virus) and COVID may result in higher-than-expected medical loss ratios (MLRs). Ransom can also be involved about potential destructive outcomes from upcoming coverage catalysts, together with Medicare Benefit Superior Discover and danger adjustment knowledge validation (RADV) remaining rule. “[T]he normal view that the mix of principally superb components in 2022 (decrease medical development, higher-than-expected MA fee enhance and rotation into U.S.-centric defensive shares) are unlikely to be replicated,” Ransom wrote in a notice to shoppers. He lower his ranking on each corporations to outperform from robust purchase and stored his inventory value targets at $615 for UnitedHealth and at $370 for Cigna. UnitedHealth’s inventory has gained 5.6% and Cigna shares have run up 39.0% yr thus far, whereas the SPDR Well being Care Choose Sector ETF
XLV,
has misplaced 4.5% and the Dow Jones Industrial Common
DJIA,
has declined 7.1%.